A Study of the Safety and Pharmacokinetics of PRO283698 in Patients With Rheumatoid Arthritis

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

This is a Phase I multicenter study that will be conducted in the United States and Europe.

Phase 1

Genentech, Inc.